ZUCHEM INC.
Engineered enzymes for activated sugar synthesis enabling enzymatic glycosylation of pharmaceuticals
- Sector
- Biotech
- Headquarters
- CHICAGO, IL
- Latest Form D
- $125K, Jun 2017
- Total capital
- $3.9M
- Federal grants
- $3.7M
- 8 awards · 2015–2018
- Rank in peer group#146 of 326
- Private capital raised
- $275K
- 2 Form D · last Jun 2017
- 113 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 1
- 15 pending · first 2023
- Rank in peer group#80 of 326
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase I · Integrated System for Rapid Production of Activated Sugars and Glycosylated Molecules$147K
- Federal grantHealth and Human S · Phase I · Integrated System for Rapid Production of Activated Sugars and Glycosylated Molecules$147K
- Private capital raisedForm D · SEC · 2nd filing$125K
- Federal grantHealth and Human S · Phase II · High-yield production of GDP-fucose for fucosylation of molecules$566K
- Federal grantHealth and Human S · Phase I · Engineered aldolase for the fermentative production of L-fucose and other rare sugars.$176K
- Federal grantHealth and Human S · Phase I · Engineered aldolase for the fermentative production of L-fucose and other rare sugars.$176K
- Federal grantHealth and Human S · Phase II · Production of Activated TDP-Deoxysugars in E. coli$465K
- Private capital raisedForm D · SEC · 1st filing$150K
Show 2 earlier federal awards
- Federal grantHealth and Human S · Phase II · High-yield production of GDP-fucose for fucosylation of molecules$1.3M
- Federal grantHealth and Human S · Phase II · High-yield production of GDP-fucose for fucosylation of molecules$711K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 326 peers
Line = medianBiotech · Molecule
- Federal grants#146 · top 45%
- Granted patents#80 · top 25%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- David DemirjianExecutive Officer, DirectorNamed in SEC Form D filings
- Douglas StewartDirectorNamed in SEC Form D filings
- Grant BrewenDirectorNamed in SEC Form D filings
- James McConougheyDirectorNamed in SEC Form D filings
- Nelson LevyDirectorNamed in SEC Form D filings
- Rajni AnejaExecutive OfficerNamed in SEC Form D filings
Show all 7 people
- Thomas ChurchwellDirectorNamed in SEC Form D filings
What it has protected
USPTO · 1 granted of 16- PendingProduction Of Xylitol From A Mixture Of Hemicellulosic SugarsUSPTOApplication 18666259
- PendingProduction of Activated TDP-Deoxysugars in Recombinant MicroorganismsUSPTOApplication 18329744
- GrantedProduction of Activated TDP-Deoxysugars in Recombinant MicroorganismsUSPTOUS 11,773,423
Show all 16 patent records
- Production Of Xylitol From A Mixture Of Hemicellulosic SugarsApr 10, 2025 · Application 18666259Pending
- Production of Activated TDP-Deoxysugars in Recombinant MicroorganismsApr 4, 2024 · Application 18329744Pending
- Production of Activated TDP-Deoxysugars in Recombinant MicroorganismsOct 3, 2023 · US 11,773,423Granted
- Production Of Xylitol From A Mixture Of Hemicellulosic SugarsJun 24, 2021 · Application 17116704Pending
- Production Of Xylitol From A Mixture Of Hemicellulosic SugarsApr 11, 2019 · Application 16167207Pending
- Activated N-Acetylated Sugars and OligosaccharidesJul 12, 2018 · Application 15736126Pending
- Activated SugarsSep 22, 2016 · Application 15172836Pending
- Activated N-acetylated Sugars And OligosaccharidesApplication PCTUS2016037577Pending
- Production Of Activated Tdp-deoxysugars In Recombinant MicroorganismsApplication PCTUS2016047315Pending
- Production of Activated TDP-Deoxysugars in E. coliApplication 62205893Pending
- Activated N-Acetylated Sugars and oligosaccharidesApplication 62175699Pending
- Activated SugarsApplication PCTUS2011048642Pending
- Production Of Xylitol From A Mixture Of Hemicellulosic SugarsApplication PCTUS2011044696Pending
- Production Of Xylitol From A Mixture Of Hemicellulosic SugarsApplication PCTUS2011021277Pending
- Production Of L-ribose And Other Rare SugarsApplication PCTUS2009054479Pending
- Production Of L-ribose And Other Rare SugarsApplication PCTUS2006031283Pending
Related companies, and why
- MIDWEST BIOPROCESSING CENTER LLCShares a founder: LEILA AMINOVA
- Encepheal Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
- PELICAN THERAPEUTICS, INC.Similar federal contract value in Biotech · null in contracts
- Acomhal Research, Inc.Similar federal contract value in Biotech · null in contracts
- Deepcell, Inc.Similar federal contract value in Biotech · null in contracts
- Neurelis, Inc.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .